Related Experiment Video
Updated: Aug 3, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues
Zhixing Yao1, William V McCall2
1Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Abstract:
Suicide is a serious and growing public health concern yet randomized controlled trials (RCTs) that inform pharmacologic treatment remain limited. We emphasize the overall need for such trials and review the literature to highlight examples of trials that have aimed to study patients at elevated risk of suicide. We discuss key examples of existing psychotropic medication trials as well as psychotherapy intervention studies that can yield important design insights. Medications that have been studied in individuals at risk for suicide include lithium, clozapine, zolpidem, prazosin, ketamine, esketamine, and aripiprazole. While important design challenges should be considered-RCTs to study suicide are feasible and much needed. Issues such as overall trial design, patient-selection criteria, and the scales/tools used to assess suicidality are discussed.
Insights
Randomized controlled trials (RCTs) for suicide prevention are crucial but limited. This review highlights the need for and feasibility of RCTs, discussing medications and design considerations for studying individuals at elevated suicide risk.
Area of Science:
- Psychiatry and Public Health
- Clinical Trial Design
Background:
- Suicide represents a significant and escalating public health crisis.
- There is a critical shortage of randomized controlled trials (RCTs) to guide pharmacologic treatments for suicide risk.
Purpose of the Study:
- To underscore the necessity of RCTs in suicide research.
- To review existing literature on trials involving patients at high risk for suicide.
- To discuss essential design considerations for future suicide prevention trials.
Main Methods:
- Literature review focusing on psychotropic medication trials and psychotherapy interventions in at-risk populations.
- Analysis of key design challenges, including patient selection and suicidality assessment tools.
- Identification of medications studied in individuals with elevated suicide risk.
Main Results:
- Several medications, including lithium, clozapine, and ketamine, have been investigated in individuals at risk for suicide.
- Psychotherapy intervention studies offer valuable insights for designing RCTs.
- Despite challenges, RCTs for suicide are feasible and urgently required.
Conclusions:
- Conducting RCTs to study suicide is both feasible and critically needed.
- Careful consideration of trial design, patient selection, and assessment tools is paramount for effective research.
- Further research using robust RCT methodologies is essential to advance suicide prevention strategies.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Therapy
Antianxiety Medications